ArticleGynecologic oncology reports2026
Single-port robotic resection of gliomatosis peritonei following immature ovarian teratoma in an adolescent: A case report.
Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gliomatosis peritonei (GP) is a rare benign condition characterized by dissemination of mature glial tissue within the peritoneal cavity, most commonly associated with immature ovarian teratoma (IOT). Its radiological appearance may closely mimic malignant recurrence or growing teratoma syndrome, posing significant diagnostic and therapeutic challenges, particularly in pediatric and adolescent patients.Case:We report the case of a 12-year-old girl with a history of IOT who developed multiple peritoneal nodules after initial surgery and chemotherapy. Imaging findings raised concern for disease recurrence, while serum tumor markers remained within normal ranges. Single-port robotic-assisted surgical exploration and resection of all visible peritoneal lesions were performed. Histopathological examination confirmed mature astrocytic glial tissue with low proliferative activity, establishing the diagnosis of GP. The postoperative course was uneventful, with rapid recovery, minimal pain, and satisfactory wound healing. No recurrence was observed during 12 months of follow-up. Conclusion: This case highlights the importance of histopathological confirmation in distinguishing GP from malignant recurrence after IOT. Single-port robotic surgery may represent a feasible minimally invasive option for the management of multifocal GP in adolescents, offering precise resection with favorable postoperative recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.